Gerard Silvestri to Carcinoma, Non-Small-Cell Lung
This is a "connection" page, showing publications Gerard Silvestri has written about Carcinoma, Non-Small-Cell Lung.
Connection Strength
8.519
-
Defining comprehensive biomarker-related testing and treatment practices for advanced non-small-cell lung cancer: Results of a survey of U.S. oncologists. Cancer Med. 2022 01; 11(2):530-538.
Score: 0.611
-
Knowledge and Practice Patterns Among Pulmonologists for Molecular Biomarker Testing in Advanced Non-small Cell Lung Cancer. Chest. 2021 12; 160(6):2293-2303.
Score: 0.591
-
Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report. Chest. 2020 07; 158(1):406-415.
Score: 0.545
-
Setting the Stage for Success in Lung Cancer: The Importance of Remembering Your (Guide)Lines. Chest. 2019 03; 155(3):456-457.
Score: 0.503
-
Assessing the Generalizability of the National Lung Screening Trial: Comparison of Patients with Stage 1 Disease. Am J Respir Crit Care Med. 2017 09 01; 196(5):602-608.
Score: 0.454
-
POINT: Is N2 Disease a Contraindication for Surgical Resection for Superior Sulcus Tumors? Yes. Chest. 2015 Dec; 148(6):1373-1375.
Score: 0.402
-
Increasing physical activity and exercise in lung cancer: reviewing safety, benefits, and application. J Thorac Oncol. 2015 Jun; 10(6):861-71.
Score: 0.388
-
Assessing the usefulness of 18F-fluorodeoxyglucose PET-CT scan after stereotactic body radiotherapy for early-stage non-small cell lung cancer. Chest. 2014 Aug; 146(2):406-411.
Score: 0.366
-
Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013 May; 143(5 Suppl):e211S-e250S.
Score: 0.336
-
Physician preferences for management of patients with stage IIIA NSCLC: impact of bulk of nodal disease on therapy selection. J Thorac Oncol. 2012 Feb; 7(2):365-9.
Score: 0.308
-
The role of molecular analyses in the era of personalized therapy for advanced NSCLC. Lung Cancer. 2012 May; 76(2):131-7.
Score: 0.305
-
A decade of advances in treatment of early-stage lung cancer. Clin Chest Med. 2011 Dec; 32(4):827-38.
Score: 0.301
-
Endobronchial ultrasound for the diagnosis and staging of lung cancer. Proc Am Thorac Soc. 2009 Apr 15; 6(2):180-6.
Score: 0.254
-
Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest. 2007 Sep; 132(3 Suppl):178S-201S.
Score: 0.227
-
A seismic shift in staging. J Thorac Oncol. 2007 Aug; 2(8):682-3.
Score: 0.225
-
Targeted therapy for the treatment of advanced non-small cell lung cancer: a review of the epidermal growth factor receptor antagonists. Chest. 2005 Dec; 128(6):3975-84.
Score: 0.201
-
Usefulness of transbronchial needle aspiration in evaluating patients with lung cancer. Thorax. 2005 Nov; 60(11):890-1.
Score: 0.200
-
The treatment of advanced non-small cell lung cancer. Curr Opin Pulm Med. 2005 Jul; 11(4):287-91.
Score: 0.195
-
The role of radiotherapy and chemotherapy for curative management of medically inoperable and stage III nonsmall cell lung cancer, and radiotherapy for palliation of symptomatic disease. Respir Care Clin N Am. 2003 Jun; 9(2):163-90.
Score: 0.169
-
The noninvasive staging of non-small cell lung cancer: the guidelines. Chest. 2003 Jan; 123(1 Suppl):147S-156S.
Score: 0.164
-
Pretreatment Invasive Nodal Staging in Lung Cancer: Knowledge, Attitudes, and Beliefs Among Academic and Community Physicians. Chest. 2022 03; 161(3):826-832.
Score: 0.152
-
Commentary: Invasive mediastinal staging for lung cancer-Quality gap, evidence gap, both? J Thorac Cardiovasc Surg. 2019 10; 158(4):1232-1233.
Score: 0.128
-
Updates Regarding Biomarker Testing for Non-Small Cell Lung Cancer: Considerations from?the National Lung Cancer Roundtable. J Thorac Oncol. 2019 03; 14(3):338-342.
Score: 0.125
-
Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews. BMJ. 1998 Sep 19; 317(7161):771-5.
Score: 0.122
-
Technical Aspects of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration: CHEST Guideline and Expert Panel Report. Chest. 2016 Mar; 149(3):816-35.
Score: 0.101
-
Rebuttal From Drs Tanner and Silvestri. Chest. 2015 Dec; 148(6):1379-1380.
Score: 0.100
-
American College of Chest Physicians and Society of Thoracic Surgeons consensus statement for evaluation and management for high-risk patients with stage I non-small cell lung cancer. Chest. 2012 Dec; 142(6):1620-1635.
Score: 0.082
-
Evaluation and treatment of high-risk patients with early-stage lung cancer. Clin Chest Med. 2011 Dec; 32(4):783-97.
Score: 0.075
-
High-dose fractionated radiotherapy to 80 Gy for stage I-II medically inoperable non-small-cell lung cancer. J Med Imaging Radiat Oncol. 2010 Dec; 54(6):554-61.
Score: 0.071
-
Lung cancer: progress in diagnosis, staging and therapy. Respirology. 2010 Jan; 15(1):44-50.
Score: 0.067
-
Underuse of surgical resection for localized, non-small cell lung cancer among whites and African Americans in South Carolina. Ann Thorac Surg. 2008 Jul; 86(1):220-6; discussion 227.
Score: 0.060
-
Variation in experts' beliefs about lung cancer growth, progression, and prognosis. J Thorac Oncol. 2008 Apr; 3(4):422-6.
Score: 0.059
-
Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007 Sep; 132(3 Suppl):202S-220S.
Score: 0.057
-
A 69-year-old with lung mass and mediastinal lymphadenopathy on chest computed tomography. Clin Gastroenterol Hepatol. 2007 Aug; 5(8):908-11.
Score: 0.056
-
Carcinoma of the bronchus 60 years later. Thorax. 2006 Dec; 61(12):1023-8.
Score: 0.054
-
Conformal high dose external radiation therapy, 80.5 Gy, alone for medically inoperable non-small cell lung cancer: a retrospective analysis. J Thorac Oncol. 2006 Feb; 1(2):112-9.
Score: 0.051
-
Multidisciplinary management of lung cancer. N Engl J Med. 2004 May 06; 350(19):2008-10; author reply 2008-10.
Score: 0.045
-
Accuracy of EUS criteria and primary tumor site for identification of mediastinal lymph node metastasis from non-small-cell lung cancer. Gastrointest Endosc. 2004 Feb; 59(2):205-12.
Score: 0.044
-
Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer. J Thorac Cardiovasc Surg. 2003 Dec; 126(6):1943-51.
Score: 0.044
-
Lunx is a superior molecular marker for detection of non-small cell lung cancer in peripheral blood [corrected]. J Mol Diagn. 2003 Nov; 5(4):237-42.
Score: 0.043
-
Detection of telomerase expression in mediastinal lymph nodes of patients with lung cancer. Am J Respir Crit Care Med. 2003 Jun 15; 167(12):1670-5.
Score: 0.041
-
Lung cancer. Invasive staging: the guidelines. Chest. 2003 Jan; 123(1 Suppl):167S-175S.
Score: 0.041
-
Endoscopic ultrasound-guided fine needle aspiration for staging patients with carcinoma of the lung. Ann Thorac Surg. 2001 Dec; 72(6):1861-7.
Score: 0.038
-
Diagnosis and staging of lung cancer. Clin Chest Med. 2000 Mar; 21(1):95-106, viii-ix.
Score: 0.034
-
First-in-Human Use of a Hybrid Real-Time Ultrasound-Guided Fine-Needle Acquisition System for Peripheral Pulmonary Lesions: A Multicenter Pilot Study. Respiration. 2019; 98(6):527-533.
Score: 0.033
-
Cost-efficacy of endoscopic ultrasonography with fine-needle aspiration vs. mediastinotomy in patients with lung cancer and suspected mediastinal adenopathy. Endoscopy. 1999 Nov; 31(9):707-11.
Score: 0.033
-
Prognostic significance of tumor proliferative fraction and DNA content in stage I non-small cell lung cancer. Am Rev Respir Dis. 1992 Sep; 146(3):707-10.
Score: 0.020